Kronos Bio, Inc. (KRON)
NASDAQ: KRON · IEX Real-Time Price · USD
1.170
+0.050 (4.46%)
At close: Jul 2, 2024, 4:00 PM
1.160
-0.010 (-0.85%)
After-hours: Jul 2, 2024, 5:36 PM EDT
Kronos Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Kronos Bio stock have an average target of 4.13, with a low estimate of 2.25 and a high estimate of 6.00. The average target predicts an increase of 252.99% from the current stock price of 1.17.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 3, 2024.
Analyst Ratings
The average analyst rating for Kronos Bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2.5 → $2.25 | Strong Buy | Maintains | $2.5 → $2.25 | +92.31% | May 3, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +412.82% | Dec 19, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $2.5 | Strong Buy | Maintains | $9 → $2.5 | +113.68% | Dec 19, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +669.23% | Nov 27, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +669.23% | Aug 21, 2023 |
Financial Forecast
Revenue This Year
7.79M
from 6.29M
Increased by 23.93%
Revenue Next Year
3.34M
from 7.79M
Decreased by -57.19%
EPS This Year
-1.60
from -1.95
EPS Next Year
-1.53
from -1.60
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 10.9M | 5.3M | n/a | 84.0M | 278.3M |
Avg | 7.8M | 3.3M | n/a | 81.6M | 270.3M |
Low | 2.5M | n/a | n/a | 78.4M | 259.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 74.0% | -32.6% | - | - | 241.0% |
Avg | 23.9% | -57.2% | - | - | 231.3% |
Low | -61.0% | - | - | - | 218.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.23 | -1.11 | -1.40 |
Avg | -1.60 | -1.53 | -1.77 |
Low | -1.91 | -1.81 | -2.11 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.